Search All News
Peter encourages others to look into clinical trials and not lose hope.
Dr. Jeffrey Bruce: "This new approach has the potential to transform treatment for patients with brain cancer, where the outlook for survival remains very poor."
Results of a multi-center study, co-led by Dr. Richard Carvajal, demonstrates a promising new immunotherapy for patients with rare uveal melanoma.
Melissa Accordino, MD, tackles solutions to long-term side effects, like peripheral neuropathy, that some breast cancer survivors experience after overcoming the disease.
- September 26, 2022
During First Lady Jill Biden's Columbia Sept. 21 visit, she singles out patient, Mario Sambula and his special connection with clinical trials nurse navigator, Brianne Bodin.
Source:CUIMC NewsroomSeptember 23, 2022
As part of the Biden Administration's Cancer Moonshot initiative, First Lady Jill Biden and Queen Letizia of Spain visited Columbia University's cancer center on Sept. 21.
- September 21, 2022
First Lady Jill Biden and Queen Letizia of Spain underscore Columbia Cancer's work in addressing health inequities, improving diversity in clinical trials and advancing critical cancer research.
- July 18, 2022
Under her directorship, Dr. Karen Antman led the expansion of the Cancer Center's clinical arm, infrastructure and multi-disciplinary care.
Source:NRG OncologyJune 28, 2022
Dr. Andrew Lassman: "These trials transformed our understanding of the clinical behavior of molecularly defined gliomas and contributed to the classification of gliomas used globally today."
Source:SWOG Cancer Research NetworkMay 27, 2022
A study, led by Dr. Dawn Hershman, tested whether standing orders embedded in electronic medical records systems could improve prescribing practice for CSFs and lower incidence of febrile neutropenia.
- March 28, 2022
A new study led by Dr. Andrew Lassman addresses safety and efficacy of infigratinib, a fibroblast growth factor receptor (FGFR)-tyrosine kinase inhibitor, for patients with recurrent glioblastomas.
- February 9, 2022
Carmela Brunelli has remained in remission after completing a trial that offers a promising, entirely new bladder-saving treatment option for patients.
- October 29, 2021
Sharon Howell had an encouraging response as a patient in the I-SPY clinical trials, and the outcome could also translate to a lower likelihood of her cancer coming back in the future.